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ttp://dx.doi.org/10.1016/j.ajpath.2014.06.016Diabetic corneal neuropathy can result in chronic, sight-threatening corneal pathology. Although the
exact etiology is unknown, it is believed that a reduction in corneal sensitivity and loss of neurotrophic
support contributes to corneal disease. Information regarding the relationship between nerve loss and
effects on the corneal epithelium is limited. We investigated changes in the corneal epithelium and
nerve morphology using three-dimensional imaging in vivo and in situ in a streptozotocin-induced
diabetic mouse model. Streptozotocin-treated mice showed increased levels of serum glucose and
growth retardation consistent with a severe diabetic state. A reduction in the length of the subbasal
nerve plexus was evident after 6 weeks of disease. Loss of the subbasal nerve plexus was associated with
corneal epithelial thinning and a reduction in basal epithelial cell density. In contrast, loss of the
terminal epithelial nerves was associated with animal age. Importantly, this is the ﬁrst rodent model of
type 1 diabetes that shows characteristics of corneal epithelial thinning and a reduction in basal
epithelial cell density, both previously have been documented in humans with diabetic corneal neu-
ropathy. These ﬁndings indicate that in type 1 diabetes, nerve ﬁber damage is evident in the subbasal
nerve plexus before terminal epithelial nerve loss and that neurotrophic support from both the subbasal
nerve plexus and terminal epithelial nerves is essential for the maintenance of corneal epithelial ho-
meostasis. (Am J Pathol 2014, 184: 2662e2670; http://dx.doi.org/10.1016/j.ajpath.2014.06.016)Supported in part by NIH grants R01 EY018219 (D.M.R.), R01
EY013322 (W.M.P.), Core grant EY020799, OneSight Research Founda-
tion (D.M.R.), a Career Development Award (D.M.R.), and an unrestricted
grant from Research to Prevent Blindness, Inc.
Disclosures: None declared.Diabetes mellitus (DM) is a severe metabolic disease with
increasing prevalence worldwide. Diabetic neuropathy is one
of the most common complications in DM and increases in
incidence with both age and duration of disease.1 At the ocular
surface, loss of corneal innervation in DM is associated with
reduced corneal sensitivity and altered tear secretion.2e4
Reduced aqueous tear production from decreased lacrimal
gland innervation and an abnormal blink reﬂex contribute to
the high incidence of dry eye that frequently is encountered
clinically. In addition, loss of trophic support, which is
essential for homeostasis of the epithelium, is believed to
contribute to epithelial fragility, corneal erosions, and persis-
tent epithelial defects.5 Changes in corneal thickness also have
been reported. In the earlier stages of disease, central corneal
thickening occurs as a result of endothelial dysfunction and
increased corneal edema.6,7 Later stages of disease, however,
result in thinning of the corneal epithelium,which is associated
with a more severe neurotrophic state.8 Restoration of corneal
epithelial homeostasis and the associated corneal nerve plexus
presents an important clinical challenge because many of thesestigative Pathology.
.neurotrophic conditions are highly refractory to conventional
therapies.
In vivo confocal microscopy (IVCM) is used increasingly
in clinical studies to evaluate disease-related changes in the
subbasal nerve plexus (SBNP). In diabetes, morphologic
alterations in the SBNP have been associated with both
retinopathy and peripheral neuropathy.9e12 Although rapid
and noninvasive, the use of confocal microscopy in clinical
studies prohibits examination of the terminal epithelial
nerves (TENs) and raises many questions regarding whether
the loss documented by the confocal examination represents
one or more ﬁbers, and the type of ﬁbers affected.13 To
address this gap, immunohistochemical studies using rodent
models of diabetes have investigated the effects of
Corneal Epithelial Changes in Diabeteshyperglycemia on the SBNP and TENs. By using two-
dimensional imaging techniques, these studies have re-
ported reductions in both the SBNP and TENs, with early
loss of TENs preceding SBNP damage.14 However, because
of the tortuosity and complex branching patterns of the
TENs as they run throughout the corneal epithelium, anal-
ysis of TENs from two-dimensional data sets limit the data
that can be extracted and therefore requires more advanced
three-dimensional (3D) modeling. Moreover, none of the
rodent studies to date have shown a detectable effect on
central corneal epithelial thickness or basal epithelial cell
density (BECD), as seen in humans, as a consequence of
disease state or nerve loss.14,15
Here, we investigated the effects of type 1 DM on the
mouse corneal epithelium. Our primary objective was to
evaluate the effects of type 1 DM on total corneal and
sublayer thickness and BECD.16,17 Our secondary objective
was to assess the corresponding effects on the neural ar-
chitecture using 3D volumetric reconstruction of the SBNP
and TENs in situ. This allowed for a systematic evaluation
of corneal nerve thickness and cellular changes in response
to disease duration and animal age.
Materials and Methods
Animals
Thirty-one 6-week-old C57/BL6 male mice purchased from
the Mouse Breeding Core Facility at The University of Texas
Southwestern Medical Center were used in this study. The
high-dose streptozotocin (STZ) induction protocol from the
Animal Models of Diabetic Complications Consortium was
used to induce a type 1 diabetic state, as approved by the
University Institutional Animal Care and Use Committee.
Brieﬂy, fasting mice underwent a single i.p. injection with
150 mg/kg STZ (Sigma, St. Louis, MO) in citrate buffer, pH
4.5. Mice were subjected to a 4-hour fast before injection.
Age-matched control mice were injected with citrate buffer
alone. Before treatment, mice were weighed and serum
glucose measurements were obtained. For serum glucose
determination, blood was sampled from the tip of the tail vein
using a OneTouch Ultra Mini glucose monitor (LifeScan,
Milpitas, CA). Diabetes was conﬁrmed by day 3. All serum
glucose measurements were performed after a minimum
fasting time of 5 hours. A fasting serum glucose reading
greater than 300 mg/dL was considered diabetic. All control
mice remained normoglycemic. On the day of the injection,
mice were provided with 10% sucrose water to prevent
sudden hypoglycemia. Mice were assessed for body weight,
serum glucose level, and corneal changes after either 6 or 12
weeks of hyperglycemia, which corresponded to animal ages
of 12 and 18 weeks, respectively. Before enucleation, mice
were euthanized under anesthesia by cervical dislocation. All
animals were treated according to the Association for
Research in Vision and Ophthalmology statement for the use
of animals in ophthalmic and vision research.The American Journal of Pathology - ajp.amjpathol.orgIVCM
IVCM was performed using a modiﬁed Heidelberg Retina
Tomograph Rostock Corneal Module (Heidelberg, Ger-
many).16,17 Before scanning, mice were anesthetized with a
single injection of 50 mg/kg ketamine and 5 mg/kg xylazine
and one drop of topical proparacaine 0.5% ophthalmic solu-
tion (Bausch & Lomb, Tampa, FL). Lubrication was main-
tained on the contralateral eye using Refresh Plus (Allergan,
Irvine, CA). To enhance epithelial viewing, a silicon washer
was placed on the outer edge of the TomoCap (Heidelberg,
Germany) to generate a thin layer of space between the
TomoCap tip and the surface epithelium.17 The dimensions of
the washer were as follows: 1.2-cm outer diameter, 3-mm
inner diameter, and 600-mm thick (Specialty Silicone Prod-
ucts, Inc., Ballston Spa, NY). Image acquisition was per-
formed as previously described.17 Corneas were scanned at a
lens speed of 30 mm per second with 1-mm increment steps. A
minimum of three scans was performed on each cornea.
Immunoﬂuorescence
Whole globes were removed and incubated in 1.5 mg/mL
Dispase (Gibco, Grand Island, NY) in phosphate-buffered
saline (PBS) for 2 hours at room temperature with gentle
agitation. Corneas were excised and ﬁxed immediately in
RNase-free 4% paraformaldehyde (Electron Microscopy
Sciences, Fort Washington, PA) in PBS for 40 minutes at
room temperature. After washing with PBS, corneal tissue
was permeabilized and blocked with 1% bovine serum al-
bumin and 0.2% Triton X-100 (Sigma, St. Louis, MO) in
PBS for 2 hours at room temperature. Corneal nerves then
were stained with 3.3 mg/mL neuronal class III b-tubulin
rabbit polyclonal antibody (MRB-435P; Covance, Emery-
ville, CA) in 1% bovine serum albumin and 0.2% Triton
X-100 in PBS overnight at 4C. After washing, corneas
were incubated in 6.7 mg/mL ﬂuorescein isothiocyanatee
conjugated secondary antibody (Alexa488; Cell Signaling,
Danvers, MA) with 0.5% bovine serum albumin and 0.1%
Triton X-100 in PBS for 2.5 hours at room temperature.
Propidium iodide (5 mg/mL; Invitrogen, Grand Island, NY)
was added to counterstain epithelial cell nuclei for the ﬁnal
hour. Corneas were mounted on glass-bottom tissue culture
dishes (MatTek, Ashland, MA) using a 75% vol/vol solution
of glycerolePBS and imaged on a Leica SP2 laser scanning
confocal microscope (Leica Microsystems, Heidelberg,
Germany). For each cornea, a single 20 image magniﬁca-
tion was acquired to evaluate the overall distribution of the
SBNP. By using a 63 water objective, three representative
images were acquired at an image zoom of 2.0 for subsequent
image processing and analysis.
Image Analysis
Corneal changes in vivo were assessed using IVCM. Mea-
surements of total corneal, epithelial, and stromal thickness2663
Figure 1 Measurements of body weight and serum glucose level in STZ-
treated mice. Body weight was reduced signiﬁcantly in the STZ-treated
group (light gray) compared with the vehicle-treated controls (dark gray)
at 12 weeks (n Z 6) (A) and at 18 weeks (n Z 8) (B). There were no
differences between the groups at baseline. Serum glucose level was
increased signiﬁcantly at 12 weeks (n Z 6) (C) and at 18 weeks (n Z 8)
(D) in the STZ-treated groups compared with the vehicle-treated controls.
There were no differences in serum glucose level at baseline in either
group. Data are expressed as means  SD. ***P < 0.001, ****P < 0.0001.
Cai et alvalues were determined using our in-house confocal mi-
croscopy through focusing program.17 For in situ morpho-
logic measurements, data sets were obtained using a laser
scanning confocal microscope and used to generate 3D
image stacks. To measure BECD from the 63 image
stacks, propidium-iodideestained nuclei within the basal
epithelial cell layer were counted manually using Meta-
Morph software version 7.7.0.0 (Molecular Devices, Inc.,
Sunnyvale, CA). The total nerve ﬁber length of the SBNP
and TENs was determined using Imaris software version
7.3.1 (BitPlane AG, South Windsor, CT). Within Imaris,
surface renderings were generated to model the corneal
epithelium and corneal nerves in three dimensions. The
FilamentTracer function then was used to trace all subbasal
nerve ﬁbers and TENs. This allowed for a combination of
automated analysis as well as operator decision to generate a
model most representative of the nerve plexus. The SBNP
and TENs were analyzed separately. Once the volume
renderings were complete, the software program automati-
cally quantiﬁed the total length of the nerve ﬁbers from the
SBNP and TENs from the resultant 3D models. All mea-
surements were performed by a masked observer (D.C.).
Statistics
Statistical analysis was performed using SigmaPlot 11.0
(Systat Software, Inc., San Jose, CA). All data were
expressed as means  SD. For comparisons between two
groups, the Student’s t-test was used to determine which
groups were signiﬁcantly different. For non-normal distri-
butions, a Mann-Whitney rank-sum test was used. To
analyze the effects of multiple factors, a two-way analysis of
variance was used. To determine relationships between
variables, a Pearson product moment correlation coefﬁcient
was determined. Statistical signiﬁcance was set at P < 0.05.
Results
Effects of STZ-Induced Type 1 Diabetes on Body Weight
and Serum Glucose Levels
All mice injected with STZ failed to gain weight compared
with the vehicle-injected controls. At 12 weeks, the control
animals had an increase of 25.8% in body weight when
compared with diabetic mice (Figure 1A). Similarly, at 18
weeks, body weight was increased 29.2% in control mice,
with no increase over baseline in diabetic animals
(Figure 1B). Consistent with failure to thrive, all STZ-treated
mice showed observable growth reduction compared with
age-matched controls. There was no statistical difference in
body weight between STZ-injected mice and vehicle-treated
controls at baseline. In contrast to body weight, analysis of
serum glucose levels conﬁrmed a signiﬁcant increase in the
STZ-treated mice. There was a 194.4% increase in serum
glucose level in the STZ-treated mice at 12 weeks compared
with controls (Figure 1C). There was a further 210.5%2664increase in serum glucose level at 18 weeks in STZ-treated
mice over controls (Figure 1D). There was no statistical
difference between either group at baseline.Effects of Type 1 Diabetes on the Corneal Epithelium
The effects of type 1 diabetes on the full-thickness mouse
cornea and surface epithelium was evaluated using IVCM.
Representative images are shown in Figure 2 and
Supplemental Video S1. After 12 weeks of STZ-induced
diabetes, there was a 7.2% reduction in total corneal
thickness; however, this ﬁnding was not signiﬁcant
(Table 1). An analysis of the sublayer corneal thickness
showed that this effect was mediated by a decrease in
stromal thickness (10.2% thinner in the STZ-treated group
compared with controls) whereas there was only a 1.6%
reduction in thickness of the corneal epithelium. At 18
weeks of disease, the total corneal thickness was reduced
signiﬁcantly by 10.2% in STZ-treated mice compared with
controls (P Z 0.011). In contrast to 12 weeks, this was
accompanied by signiﬁcant thinning of the corneal epithe-
lium (12.2% reduction compared with controls; PZ 0.026).
Although not signiﬁcant, stromal thickness in this group
decreased similarly by 9.3%.
Double-labeling of corneal nerves and epithelial nuclei
allowed for an assessment of epithelial perturbations in the
normal and diseased states (Figure 3, AeC). Of note, BECD
was decreased signiﬁcantly in the corneal epithelium of
diabetic mice. There was a 6.3% reduction at 12 weeks
(Figure 3D) (PZ 0.011) and a 4.5% reduction at 18 weeks
(Figure 3E) (P Z 0.012). Comparison of the right and leftajp.amjpathol.org - The American Journal of Pathology
Figure 2 Quantitative 3D in vivo confocal microscopy. Representative
images showing the surface epithelium (A), the basal lamina with subbasal
nerve plexus (SBNP) (B), and the endothelium (C). B: Note the presence of
an inﬁltrated dendritic cell (arrow). D: An X-Z projection shows all corneal
layers. E: Three-dimensional rendering of the full-thickness cornea. F: In-
tensity proﬁle generated from backscattered light allows the determination
of total and sublayer thickness. Scale barZ 100 mm (C). bl, basal lamina;
endo, endothelium; epi, epithelium.
Corneal Epithelial Changes in Diabeteseyes of individual mice showed no signiﬁcant difference in
BECD.Table 1 Summary of Corneal Thickness Values
Animal age
STZ-treated
group (mm)
Vehicle-only
control (mm)
P
value
12 weeks
Total corneal thickness 98.3  14.1 105.9  13.6 0.291
Epithelial thickness 36.8  5.1 37.4  6.5 0.834
Stromal thickness 61.5  9.4 68.5  9.1 0.156
18 weeks
Total corneal thickness 97.6  8.5 108.7  4.8 0.011*
Epithelial thickness 34.0  3.0 38.6  3.8 0.026*
Stromal thickness 63.6  7.2 70.1  5.5 0.085
Corneal thickness values are means  SD.
*P < 0.05.Effects of Type 1 Diabetes on the Subbasal Plexus and
TENs
From the 3D volumetric images, three different nerve
morphologies were observed: simple, ramifying, and com-
plex. Representative images are shown in Figure 4. Simple
TENs were identiﬁed as branching from the SBNP and
projecting anteriorly toward the corneal surface (Figure 4, A
and B). Similar to simple nerves, ramifying nerves branched
from the SBNP and ran anteriorly toward the corneal sur-
face. However, ramifying nerves underwent subsequent
branching within either the wing or squamous epithelial cell
layers, and continued to course parallel to the SBNP
(Figure 4, C and D) throughout superﬁcial cell layers. The
length of these parallel ﬁbers varied greatly and often
spanned distances of >3 to 5 epithelial cells in length. In
contrast to simple and ramifying nerves, complex TENs
showed a multibranching pattern among wing and surface
epithelial cells (Figure 4, E and F), with evidence ofThe American Journal of Pathology - ajp.amjpathol.organastomoses detected between more apically localized nerve
ﬁbers (not shown).
Low-magniﬁcation views of the SBNP showed visible
nerve ﬁber degradation with patchy regions of nerve ﬁber
loss in the diabetic cornea compared with the vehicle-treated
control, including focal loss within the whorl-like vortex
(Figure 5, A and B). Within the patchy areas of SBNP
damage, the overall length of the TENs seen branching from
the remaining subbasal nerve ﬁbers appeared relatively
unchanged. Representative 3D renderings and segmentation
of the SBNP and TENs generated in normal and diabetic
corneas are shown in Figure 5, CeF and in Supplemental
Videos S2, S3, S4, and S5. Only a small proportion of
subbasal nerve ﬁbers showed evidence of TEN branching in
the normal cornea. In contrast, in the diabetic cornea, there
were fewer nonbranching ﬁbers observed.
To investigate quantitative changes in the SBNP and
TENs, the total length of the SBNP and TENs were calcu-
lated independently using Imaris. By using this method, we
found a signiﬁcant reduction in total nerve ﬁber length in the
SBNP in diabetic mice compared with controls (P < 0.001
at 12 and 18 weeks, respectively). This decrease was more
pronounced at 18 weeks, which showed a 40.5% reduction
in length compared with a 31% reduction at 12 weeks
(Figure 6A). The interaction between disease and animal
age was signiﬁcant (P Z 0.046). In contrast to the SBNP,
there was only a small difference between the diabetic and
control groups in TEN length at either 12 or 18 weeks
(Figure 6B) (P Z 0.034). However, there was an obvious
reduction in TEN length in both the diabetic and control
groups at 18 weeks compared with 12 weeks (Figure 6B)
(P < 0.001). There was no interaction between animal age
and disease (PZ 0.860). Similar to the TENs, there was no
interaction between age and disease for BECD (PZ 0.359).
There was no signiﬁcant difference in the length of the
SBNP, TENs, or BECD between the left and right eyes.
Signiﬁcant correlations were found among all three outcome
measures (Figure 7). The weakest correlation was between
TENs and the SBNP (r Z 0.35, P Z 0.005). Moderate
correlations were seen between BECD and TENs (rZ 0.40,
PZ 0.002) and BECD and SBNP (rZ 0.44, PZ 0.0004).2665
Figure 3 Three-dimensional reconstruction of
the corneal epithelium and associated epithelial
nerves. Corneal nerves were labeled with neuronal
bIII tubulin (green) and nuclei were counter-
stained with propidium iodide (red, 63). A:
Three-dimensional surface-rendering view from the
apical surface shows the spatial distribution of the
subbasal nerve plexus (SBNP). B: The view from
the side shows the terminal epithelial nerves
(TEN)s. C: The view from within the corneal
epithelium shows the branching patterns and in-
terconnections among TENs (solid arrows indicate
TENs, open arrows indicate the SBNP). D and E:
The mean density of basal epithelial cells was
reduced signiﬁcantly in the streptozotocin (STZ)-
treated animals compared with vehicle-treated
controls at both 12 weeks (P Z 0.011, n Z 8
for both STZ and control groups) (D) and 18 weeks
(P Z 0.012, n Z 8 for both STZ and control
groups) (E). Data are representative of
means  SD. Scale bars: 8 mm (AeC).
Cai et alDiscussion
There were two signiﬁcant ﬁndings in this study. First, the
central corneal thickness was reduced in the severely dia-
betic state. The reduction in corneal thickness was evident at
both the stroma and epithelium levels. Clinically, changes in
corneal thickness have been reported previously in dia-
betes.6e8 By using tandem scanning confocal microscopy,
Rosenberg et al8 reported epithelial thinning in patients with2666signiﬁcant corneal neuropathy. However, they reported an
increase in stromal thickness caused by corneal edema.
Here, we found that stromal thickness was reduced at both
disease time points and was associated with signiﬁcant
growth retardation in the diabetic state. This ﬁnding sug-
gests that the widespread effects of hyperglycemia may
impact and/or disrupt stromal development. Although not
investigated here, stromal biomechanical properties have
been reported to be altered in diabetes. These include anFigure 4 Morphology of terminal epithelial
nerves (TEN). Three-dimensional surface render-
ings of the subbasal nerve plexus (white) and TENs
(blue). Propidium iodideestained nuclei are
shown in red. Short simple nerve (A and B), long
simple nerve (C and D), and a complex nerve (E
and F) are shown. B, D, and F: Corresponding
zoomed regions from A, C, and E, respectively, as
indicated by the dotted box. Scale bars: 8 mm (A,
C, and E).
ajp.amjpathol.org - The American Journal of Pathology
Figure 5 Distribution of loss in the subbasal nerve plexus (SBNP).
Representative 20 images of neuronal bIII tubulinestained nerves of the
full SBNP in control (A) and 18-week streptozotocin-treated (B) corneas.
Note both diffuse nerve loss with patchy focal areas of dropout. B: Arrow
indicates the damage at the area of the whorl. C and D: Three-dimensional
surface rendering of the SBNP and terminal epithelial nerves (TEN) in
normal (C) and diabetic (D) corneas. Three-dimensional nerve modeling
and segmentation using Imaris Filament. E and F: The SBNP is shown in red
and TENs are shown in blue. Normal SBNP and TENs (E), diabetic SBNP and
TENs (F). Scale bars: 70 mm (B);10 mm (C and D).
Corneal Epithelial Changes in Diabetesincrease in corneal hysteresis, which has been postulated to
be caused by increased accumulation of advanced glycation
end products, and abnormalities in collagen organization.18
The role of chronic hyperglycemic stress on keratocyte
function and the downstream impact on stromal remodeling
represents an important avenue of future research.
In contrast to the stroma, central epithelial thinning was
present only in the diabetic animals. We also reported a
slight, but signiﬁcant, decrease in BECD within the centralFigure 6 Effects of age and disease on the subbasal nerve plexus (SBNP) a
signiﬁcantly as a consequence of disease; however, longer disease duration was as
contrast, TEN length was affected minimally by animal age, and was not dependent
a signiﬁcant difference in basal epithelial cell density as a function of disease, wh
P Z 0.359). Data are representative of means  SD. *P < 0.05, ***P < 0.001.
The American Journal of Pathology - ajp.amjpathol.organd paracentral corneal epithelium. This decrease was
similar to an earlier report by Chang et al19 that showed a
reduction in BECD in humans with diabetic retinopathy. In
agreement with that study, the reduction in BECD paralleled
the loss of the SBNP. This change in BECD, coupled with
corneal epithelial thinning, indicates a disruption in the
normal homeostasis of the corneal epithelium. Although it is
unknown whether corneal epithelial changes in diabetes are
driven directly by a loss of neurotrophic support from the
SBNP or indirectly through alterations in corneal sensitivity
and the blink reﬂex,20 the ﬁndings from the present study
suggest a partial contributory component for both.
It is well-established clinically that ocular surface
inﬂammation and dry eye are associated frequently with
diabetes.21,22 This is caused in part by direct hyperglycemia-
mediated damage to the lacrimal gland.23e25 Because dry
eye is accompanied by an increase in apoptotic-driven sur-
face cell desquamation,26 a potential increase in epithelial
surface cell loss that is greater than the basal epithelial cell
mitotic rate would result in a net thinning of the corneal
epithelium, as seen in the diabetic animals. A thinned
compromised epithelium that fails to maintain optimal
lubrication in the presence of an inadequate blink response
predisposes the cornea to an increased risk of surface
epithelial damage.27 Similarly, a disruption in the normal
barrier function of the epithelium may contribute to an
increased risk of infection, as has been reported previously
in the diabetic eye.28e30
In the absence of disease, murine corneal thickness values
have been reported to increase during the ﬁrst 4 to 8 weeks
of postnatal life, leveling off and remaining relatively un-
changed throughout adulthood.31 Previous studies have
investigated central corneal and epithelial thickness in the
C57/BL6 mouse cornea. Henriksson et al32 used conven-
tional light microcopy of glutaraldehyde-ﬁxed tissue in situ
and reported a mean central corneal thickness of 137.02 mm
with measurements of 40.59 and 90.88 mm for thend terminal epithelial nerves (TEN). A: Length of the SBNP was reduced
sociated with greater loss (age, PZ 0.041; interaction, PZ 0.046). B: In
on health status (health, PZ 0.034; interaction, PZ 0.860). C: There was
ich was not inﬂuenced by age or interaction (age, PZ 0.638; interaction,
Ctrl, control.
2667
Figure 7 Relationship between subbasal nerve plexus (SBNP), terminal
epithelial nerves (TEN), and basal epithelial cell density (BECD). There was
a moderate correlation between changes in the SBNP and a reduction in
BECD (R Z 0.44, P Z 0.000399) and between TENs and BECD (R Z 0.40,
PZ 0.00181). Loss of TEN was correlated only weakly with loss of the SBNP
(R Z 0.35, P Z 0.00545).
Cai et alepithelium and stroma, respectively. More recently, Zhang
et al33 used two-photon imaging to assess corneal thickness
in vivo in C57/BL6 mice and found central values of 116.6,
39.9, and 76.7 mm for total, epithelial, and stromal thick-
nesses, respectively. Spectral domain optical coherence to-
mography also has been used to assess corneal thickness
in vivo and in situ.31 In this study, the investigators reported
a central corneal thickness value of 106 mm for adult mice
in vivo compared with 141 mm for ﬁxed tissue in situ.
Because of limitations when using optical coherence to-
mography, sublayer thickness values were not reported.
Here, total corneal thickness values in control mice
measured 105.9  13.6 mm and 108.7  4.8 mm using
IVCM, at approximately 12 and 18 weeks of age, respec-
tively. These ﬁndings are in agreement with the previous
in vivo optical coherence tomography reports and support
the use of IVCM for corneal thickness determination in this
study.
To date, all other studies evaluating corneal thickness in
STZ-treated rat models have reported that corneal thickness
is unchanged in diabetic animals compared with normal
controls.14,15 This could be a result of variability in the rat
corneal response compared with the mouse, differences in the
STZ procedure used, or a limitation of the imaging system. In
their study using STZ-treated Sprague-Dawley rats, Yin
et al15 used the ConfoScan (Nidek, Fremont, CA) to evaluate
corneal thickness after a disease duration of 8 weeks. They
reported an average corneal thickness of 170 mm, which was
unchanged as a consequence of diabetes. However, because
of the lack of applanation and lower axial resolution of the
ConfoScan, it is possible that the instrument was unable to
detect small differences in corneal thickness between the test
and control groups. Davidson et al14 also evaluated corneal
thickness in Sprague-Dawley rats after 8 weeks of diabetes.
In their study, measurements were obtained using the Hei-
delberg Retina Tomograph confocal microscope. The mean2668corneal thickness was reported as 137 mm in control rats, 126
mm in diabetic animals, and 121 mm in diabetic animals
receiving treatment for their disease. Although this decrease
was not statistically signiﬁcant, it still represents an 8%
reduction in total corneal thickness in the diabetic rodent
cornea, which is consistent with our results.
The second key ﬁnding in this study was that a reduction in
the total length of the SBNP was associated with hypergly-
cemia, whereas a decrease in the TENs occurred as a conse-
quence of normal maturation. The loss of SBNP in response to
prolonged hyperglycemia is in agreement with previous rodent
and human clinical models.8e12,15,27,34 This response was
greatest at 18 weeks and is consistent with duration of disease
as a risk factor for diabetic neuropathy.1 Multiple mechanisms
have been proposed to play a role in the onset and progression
of diabetic neuropathy. These include hyperglycemia-induced
inﬂammation and oxidative stress, altered metabolic and
signaling pathways, and vascular insufﬁciency. In the cornea,
a reduction in acetylcholine-mediated vascular relaxation of
the posterior ciliary artery has been shown to be associated
with decreasing nerve ﬁber length in the SBNP.35 Thus, in
addition to locally derived mediators, systemic factors asso-
ciated with diabetes may play a signiﬁcant role in the deteri-
oration of the SBNP. This has been supported by clinical
studies that showed that reductions in systemic risk factors
associated with diabetes as well as successful pancreas trans-
plantation are associated with an enhancement in SBNP
morphology.11,36,37
Earlier ﬁndings by Davidson et al14 using two-dimensional
corneal imaging reported that the TENs in the diabetic rodent
are lost before any detectable damage occurs in the SBNP.
Here, although we did see changes at the whorl-like vortex
that accompanied patchy loss of the SBNP,38 we were unable
to detect an early loss or degradation of the TENs before the
SBNP changes. Instead, we observed fewer nonbranching
ﬁbers within the SBNP in the diabetic cornea when compared
with controls. Although we recognize that the small ﬁeld of
view in the high-magniﬁcation image prohibits the ability to
follow the nonbranching nerves over longer distances, the
observation that nonbranching nerves may be lost ﬁrst would
indicate that robust SBNP loss is required before substantial
effects on the TENs would be seen. Because terminal corneal
nerve ﬁbers are responsible for relaying nociceptive sensory
input, a decrease in TENs would be required before a loss in
corneal sensitivity.39 This would explain ﬁndings by Yin
et al,15 who reported only a modest correlation between
changes in the SBNP and corneal sensitivity, as measured by
corneal touch thresholds, in their STZ-treated rat model.
Indeed, this hypothesis also is consistent with clinical data
showing that early changes in the SBNP are not associated
with loss of corneal sensation but that damage of a much
greater magnitude is required.8
Length of the TENs was reduced in older animals inde-
pendent of disease. This age-related effect was not evident
at the level of the SBNP. The ﬁnding of an age-related
loss in TENs is consistent with a previous study evaluatingajp.amjpathol.org - The American Journal of Pathology
Corneal Epithelial Changes in Diabetesage-related changes in the mouse cornea.40 In that study, the
investigators showed that corneal nerve terminal density
increased from postnatal day 1 until 8 weeks, with a gradual
reduction onward. This natural pruning of TENs in the
cornea may reﬂect normal age-related remodeling of the
TENs. Additional studies using older animals are required to
examine the contributory relationship between loss of the
TENs, corneal sensitivity, and lacrimal input.
Although immunoﬂuorescent studies permit analysis of
the corneal TEN architecture, which is beyond the current
resolution limits of the confocal microscope in vivo, there
were limitations to this technique. Speciﬁcally, the presence
of any background ﬂuorescence within the image can induce
image artifacts and result in the appearance of nerve ﬁbers
that may not be present. This factor was controlled for in the
current study by using a combination of automatic and
manual nerve ﬁber tracings to allow for optimal reproduction
of the nerves in the 3D models. A second potential limitation
to the present study was in the regional nature of nerve ﬁber
loss within the SBNP. Because three predeﬁned regions were
selected for imaging in all samples, this resulted in increased
variability in the data set. The use of three predetermined
regions, however, was essential to control for any investi-
gator bias in region selection during imaging.
Conclusions
This is the ﬁrst rodent model of type 1 diabetes that shows
corneal epithelial thinning and changes in BECD associated
with diabetic corneal neuropathy that parallel changes re-
ported in humans. These ﬁndings indicate that the patho-
physiological effects of hyperglycemia impact SBNP before
TEN loss and that neurotrophic support from both SBNP
and TENs is essential for the maintenance of corneal
epithelial homeostasis. Because changes in the corneal
nerve architecture and corneal sensitivity increasingly are
being implemented as outcome measures in studies evalu-
ating disease severity, comorbidity, and therapeutic modal-
ities in diabetes, it is imperative to elucidate the
pathophysiological mechanisms that underlie these changes.
Further studies that incorporate the use of human donor
corneal tissue to investigate these changes systematically are
required to conﬁrm and extend these ﬁndings.
Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2014.06.016.
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